LEADER 01027nam0 2200265 i 450 001 SUN0066443 005 20081124120000.0 010 $a80-584-8304- 100 $a20081124d2005 |0engc50 ba 101 $aeng 102 $aUS 105 $a|||| ||||| 200 1 $aAdolescent psychological development$erationality, morality, and identity$fDavid Moshman 205 $a2 ed 210 $aNew York$cLawrence Erlbaum Associates$dc2005 215 $axxi, 174 p.$cill.$d23 cm. 620 $aUS$dNew York$3SUNL000011 700 1$aMoshman$b, David$3SUNV052775$0724867 712 $aErlbaum$3SUNV000683$4650 801 $aIT$bSOL$c20181109$gRICA 912 $aSUN0066443 950 $aUFFICIO DI BIBLIOTECA DEL DIPARTIMENTO DI PSICOLOGIA$d16 CONS INGL 267 $e16 VS 3572 995 $aUFFICIO DI BIBLIOTECA DEL DIPARTIMENTO DI PSICOLOGIA$bIT-CE0119$gVS$h3572$kCONS INGL 267$oc$qa 996 $aAdolescent psychological development$91416901 997 $aUNICAMPANIA LEADER 03785nam 22006615 450 001 9910743224703321 005 20251113205854.0 010 $a981-16-5758-0 010 $a981-16-5759-9 010 $a981-16-5759-9 024 7 $a10.1007/978-981-16-5759-7 035 $a(MiAaPQ)EBC7001369 035 $a(Au-PeEL)EBL7001369 035 $a(CKB)22898392400041 035 $a(OCoLC)1329272590 035 $a(DE-He213)978-981-16-5759-7 035 $a(EXLCZ)9922898392400041 100 $a20220527d2022 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCancer Biomarkers in Diagnosis and Therapeutics /$fedited by Adeeb Shehzad 205 $a1st ed. 2022. 210 1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2022. 215 $a1 online resource (372 pages) 225 1 $aBiomedical and Life Sciences Series 311 08$aPrint version: Shehzad, Adeeb Cancer Biomarkers in Diagnosis and Therapeutics Singapore : Springer,c2022 9789811657580 320 $aIncludes bibliographical references. 327 $aChapter 1. Introduction to cancer biomarkers -- Chapter 2.Technologies for identification and validation of cancer biomarkers -- Chapter 3. BIOMARKERS FOR CANCER DRUG DEVELOPMENT -- Chapter 4. Clinical proteomics: diagnostics and prognostic markers of Cancer -- Chapter 5.Microbiome as cancer biomarkers -- Chapter 6. Predictive biomarkers for anticancer drugs -- Chapter 7. Biomarkers in Cancer Survival and Drug Resistance -- Chapter 8. Biomarkers in tumor recurrence and metastasis -- Chapter 9. Biomarkers for Cancer Immunotherapy -- Chapter 10. Role of Biomarkers in Personalized Medicine -- Chapter 11.Development of Novel Cancer Biomarkers for Diagnosis and Prognosis -- Chapter 12. Nanotechnology for Cancer Biomarkers. 330 $aThis book illustrates the basics and underlying molecular machinery of cancer cells and biochemical assays that detect the type and stage of cancer through cell signaling biomarkers. It starts with a brief introduction to cancer biomarkers and addresses technologies for identifying and validating cancer biomarkers, biomarkers for cancer drug development, prognostic and diagnostic biomarkers, and microbiome as cancer biomarkers. It reviews predictive biomarkers for anticancer drugs, biomarkers in cancer survival and drug resistance, biomarkers in tumor recurrence and metastasis, the role of the biomarker in immunotherapy and personalized medicine, and the development of a novel cancer biomarker. Finally, this book also underpins the role of nanotechnology in the use and detection of cancer biomarkers for enhanced sensitivity and specificity. Lastly, it discusses the challenges with biomarkers in cancer drug discovery and development. This volume is an indispensable tool for researchers working in the field of cancer and also for clinical oncologists. 410 0$aBiomedical and Life Sciences Series 606 $aTumor markers 606 $aCancer 606 $aCancer$xTreatment 606 $aNanomedicine 606 $aTumour Biomarkers 606 $aCancer Biology 606 $aCancer Therapy 606 $aCancer Nanotechnology 615 0$aTumor markers. 615 0$aCancer. 615 0$aCancer$xTreatment. 615 0$aNanomedicine. 615 14$aTumour Biomarkers. 615 24$aCancer Biology. 615 24$aCancer Therapy. 615 24$aCancer Nanotechnology. 676 $a616.994075 702 $aShehzad$b Adeeb 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910743224703321 996 $aCancer biomarkers in diagnosis and therapeutics$93560275 997 $aUNINA